Trump II Administration Cuts HIV Vaccine Research Program

The Trump administration has ended a $258 million program searching for an H.I.V. vaccine. The program conducts research that lays the groundwork for future clinical testing. National Institutes of Health officials said the agency would refocus on currently effective treatments. Earlier, the administration had cut funding for international H.I.V. mitigation and separately, nixed funding for vaccine research carried out by Moderna.